[go: up one dir, main page]

WO2020165777A1 - Vaporisateur à entrée variable à réservoir multiple préprogrammé - Google Patents

Vaporisateur à entrée variable à réservoir multiple préprogrammé Download PDF

Info

Publication number
WO2020165777A1
WO2020165777A1 PCT/IB2020/051101 IB2020051101W WO2020165777A1 WO 2020165777 A1 WO2020165777 A1 WO 2020165777A1 IB 2020051101 W IB2020051101 W IB 2020051101W WO 2020165777 A1 WO2020165777 A1 WO 2020165777A1
Authority
WO
WIPO (PCT)
Prior art keywords
vaporizable materials
flow
storage tank
setting
cannabinoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2020/051101
Other languages
English (en)
Inventor
Michael CABIGON
Steven Splinter
Denis TASCHUK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Radient Technologies Innovations Inc
Original Assignee
Radient Technologies Innovations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radient Technologies Innovations Inc filed Critical Radient Technologies Innovations Inc
Publication of WO2020165777A1 publication Critical patent/WO2020165777A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/65—Devices with integrated communication means, e.g. wireless communication means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/30—Devices using two or more structurally separated inhalable precursors, e.g. using two liquid precursors in two cartridges
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/48—Fluid transfer means, e.g. pumps
    • A24F40/485—Valves; Apertures
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/50—Control or monitoring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L12/00—Data switching networks
    • H04L12/28—Data switching networks characterised by path configuration, e.g. LAN [Local Area Networks] or WAN [Wide Area Networks]
    • H04L12/2803—Home automation networks
    • H04L12/2823—Reporting information sensed by appliance or service execution status of appliance services in a home automation network
    • H04L12/2827—Reporting to a device within the home network; wherein the reception of the information reported automatically triggers the execution of a home appliance functionality
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
    • A61M2205/123—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with incorporated reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A61M2205/3334—Measuring or controlling the flow rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3368—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3379—Masses, volumes, levels of fluids in reservoirs, flow rates
    • A61M2205/3386—Low level detectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6018—General characteristics of the apparatus with identification means providing set-up signals for the apparatus configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated

Definitions

  • the present disclosure is generally related to a vaporizing cannabinoids in controlled ways. More specifically, the present disclosure is directed to combining materials from a plurality of storage tanks and vaporizing those combined materials.
  • Cannabis has a long history being used for medicinal therapeutic, and recreational purposes.
  • the importance of cannabis in therapeutics is emphasized by the ever- increasing number of research publications related to the new indications for cannabis.
  • pharmaceutical research companies are presently developing new natural cannabinoid formulations and delivery systems to meet various regulatory requirements.
  • Cannabis is known, for example, to be capable of relieving nausea (such as that accompanying chemotherapy), pain, vomiting, spasticity in multiple sclerosis, and increase hunger in anorexia.
  • Cannabis contains a unique class of cannabinoids, phytocannabinoids, which have been extensively studied since the discovery of the chemical structure of
  • CBD tetrahydrocannabinol
  • THC tetrahydrocannabinol
  • Cannabidiol CBD
  • CBD is the major cannabinoid substituent in hemp cannabis.
  • CBD is non-psychoactive and is widely known to have therapeutic potential for a variety of medical conditions.
  • Over 113 phytocannabinoids have been identified.
  • the proportion of cannabinoids in the plant may vary from species to species, as well as vary within the same species at different times and seasons.
  • the proportion of cannabinoids in a plant may further depend upon soil, climate, and harvesting methods. Based on the proportion of the cannabinoids present the psychoactive and medicinal effects obtained from different plant varieties may vary.
  • the relative ratio of THCCBD may impact the psychoactive and therapeutic effects for users. Further, these effects may be affected by the presence and relative amounts of certain terpenoid or phenolic compounds found naturally in the cannabis plant.
  • Vape liquids are often formulated from cannabinoid-containing cannabis extracts with various diluents and excipients to a standardized concentration of certain cannabinoids.
  • extract may be taken to mean any suitable cannabinoid-containing liquid formulation suitable for vaporizing and delivery via inhalation in a vaporizing apparatus.
  • the extract may be derived from extracts of cannabis biomass, including purified extracts, distillates, concentrates and isolated cannabinoids.
  • FIG. 1 illustrates an exemplary network environment in which a system for a preprogrammed multiple tank variable input vaporization maybe implemented.
  • FIG. 2 illustrates a vaporizer device that vaporizes controlled ratios of cannabinoids and provides vapors with the controlled ratios for inhalation.
  • FIG. 3 illustrates a portion of a vaporizer device that may be used to mix contents from different storage tanks in desired ratios as the mixed contents are provided to a vaporizing element
  • FIG 4 illustrates an alternative portion of a vaporizer device that may be used to mix contents from different storage tanks in desired ratios as the mixed contents are provided to a vaporizing element.
  • FIG. 5 is a flowchart illustrating an exemplary method for preprogrammed multiple tank variable input vaporization via a cannabinoid network device.
  • FIG. 6 illustrates an alternative network environment in which a system for preprogrammed multiple tank variable input vaporization may be implemented.
  • FIG. 7 illustrates a computing system that may be used to implement an embodiment of the present invention.
  • the presently claimed invention relates to an apparatus, a method, and a non- transitory computer readable storage medium that control the vaporization of materials from a plurality of storage tanks in controlled ways.
  • An apparatus consistent with the present disclosure may include a first and a second storage tank that store different sets of materials, a heating element, and a first and a second flow device.
  • the first flow device may be coupled to the first storage tank and to the heating element and the second flow device may be coupled to the second storage tank and to the heating element
  • a first end a second set of materials may flow respectively from each of the first storage tank and the second storage tank.
  • the first flow of materials may move through the first flow device based on a first setting and the second flow of materials may move through the second flow device based on a second setting.
  • the first and second flow of materials may form a combined mixture of the first set of materials based on the first and tire second setting and the mixed combination of materials may move to the heating element and then be vaporized when the heating element is energized.
  • a method consistent with the present disclosure may include receiving a first setting associated with a first flow device and may include receiving a second setting associated with a second flow device.
  • the first flow device may be coupled to a first tank and to a vaporizing heating element.
  • the second flow device may be coupled to a second and to the vaporizing heating element.
  • the first tank may store a first set of materials and the second tank may store a second set of materials.
  • the method may then include energizing the vaporizing heating element after or as a first flow of materials moves from the first tank through the first flow device and a second flow of materials move from the second tank through the second flow device.
  • the movement of the first flow may be according to the first setting and the movement of the second flow of materials may be according to the second setting.
  • a processor executing instructions out of a memory may receive a first setting associated with a first flow device and may receive a second setting associated with a second flow device.
  • the first flow device may be coupled to a first tank and to a vaporizing heating element.
  • the second flow device may be coupled to a second and to the vaporizing heating element.
  • the first tank may store a first set of materials and the second tank may store a second set of materials.
  • the processor may then allow the vaporizing heating element to be energized after or as a first flow of materials moves from the first tank through the first flow device and a second flow of materials move from the second tank through the second flow device.
  • the movement of the first flow may be according to the first setting and the movement of the second flow of materials may be according to the second setting.
  • the flows of the first and the second set of materials may be combined to form a mixture of the first set and the second set of materials and this combination of materials may be vaporized at a the heating element when the heating element is energized.
  • Methods and apparatus consistent with the present disclosure may allow a user to leverage growing research on cannabinoids and the endocannabinoid system in order to provide and control customized therapeutic effects for medical cannabis users.
  • This invention disclosed herein allows a user to identify and achieve cannabinoid ratios that are therapeutic or recreationally desirable, yet that are not naturally present in a cannabis extract.
  • Methods and apparatus consistent with the present disclosure also provides a means for extract producers and providers to achieve cannabinoid ratios that do not naturally occur in their biomass sources, yet are desired or needed by their customer base.
  • FIG. 1 illustrates an exemplary network environment in which a system for a preprogrammed multiple tank variable input vaporization may be implemented.
  • Such network environment may include vaporizer 105 and in a cannabis network device 140. These electronic components may allow vaporizer device 105 to communicate with cannabis network device 140 via communication network 135.
  • Vaporizer device 105 includes display 110, processor 115, memory 120, communication interface 125, and power supply 130.
  • Cannabis network device 140 includes memory 145, processor 150, extract database 155, communication interface 160, combination database 175, and user database 180.
  • Vaporizer device 105 may communicate with cannabis network device via communication network 135 when providing information regarding a user of vaporizer 105 and information that identifies contents in two or more different storage tanks/cartridges at vaporizer 105.
  • Processor 115 at vaporizer 105 may execute instructions out of memory 120 to collect data from storage cartridges physically connected to vaporizer 105. This data may then be sent to cannabis network device.
  • the system of FIG. 1 may be comprised of a vaporizing apparatus 105 that allows data related to cannabinoid containing formulations or extracts stored in a first and a second source storage container to be provided to cannabis network device 140.
  • optimal or preferred cannabinoid ratios and vaporizing temperatures may be communicated to the cannabis network device 140 via communication interface 125 and communication network 135.
  • cannabis network device 140 may provide information to vaporizer 105 that is used to control quantities of specific cannabinoids that are vaporized at vaporizer 105.
  • processor 115 may control quantities of a first extract and quantities of a second extract that are provided to a vaporizing element (not illustrated in FIG. 1) at vaporizer 105.
  • Each of a set of storage tanks/cartridges at vaporizer 105 may store data or a code that may be accessed by processor 115 and this data or code may be used to identify contents included in each respective storage tank at vaporizer 105.
  • the storage tanks at vaporizer 105 may include electrical contacts that that allow processor 115 to receive data from the storage tanks.
  • each of these storage tanks may include a near field data
  • vaporizer 105 may include either a wired communication bus or a reader that allows vaporizer 105 to collect data from storage tanks that are physically connected to vaporizer 105.
  • a first storage tank or container at vaporizer 105 may hold a cannabis extract that is delivered to a vaporizing element at vaporizer device 105 and processor 115 may receive data that identifies the contents stored in this first storage tank or container.
  • a second extract container at vaporizer 105 may hold a cannabis extract that also may be provided to the vaporizing element at vaporizer device 105 after processor 115 receives data that identifies the contents stored in the second storage tank or container at vaporizer device 105.
  • cannabis network 140 may provide recommended ratios of specific cannabinoids that should be provided to a vaporizing element at vaporizer 105 based on information stored in combination database 175 or user data based 180 and this information may be used by processor 115 to control the flow of contents from either or both of the first and the second storage tanks at vaporizer 105.
  • display 110 at vaporizer 105 may allow a user to change or set factors that control the flow of contents (e.g. ratios of specific cannabinoids) from either or both of the first and the second storage tanks at vaporizer 105.
  • ratio data stored at vaporizer 105 may allow processor 115 to execute instructions out of memory 105 that results in a mixture of elements of both the first and the second storage tank at vaporizer 105 to be provided to a vaporizing element at vaporizer 105.
  • the electronics at vaporizer 105 may control the ratio of each of a set of extracts to be provided to a vaporizing element to control ratios of specific elements inhaled by a user of vaporizer 105.
  • electronics at vaporizer 105 may allow the user to adjust the ratio of each extract in each inhalation.
  • Display 110 may include a user interface that may be a touchscreen.
  • vaporizer 105 may include a selector or a type of dial that allows the user to set a desired ratio that may be used to control a flow of elements to a vaporizing element at vaporizer 105.
  • THC cannabinoid tetrahydrocannabinol
  • CBD cannabidiol
  • control electronics at vaporizer 105 may provide twice as much material from storage tank 1 as provided from storage tank 2 to a vaporizing element at vaporizer 105.
  • each of the storage tanks at vaporizer 105 may include THC and CBD in identical volumetric densities (e.g. concentrations) that may be measured in milligrams (mg) of a cannabinoid per milliliter (ml) of a cannabinoid containing substance/extract.
  • data read from each of the respective storage tanks at vaporizer 105 may identify volumetric densities of specific cannabinoids included in those storage tanks. This volumetric density data may be used to adjust flows of cannabinoid containing materials to a vaporizing element based on a cannabinoid ratio stored in memory 120 of vaporizer 105. For example, when the first tank stares THC with a volumetric density of 1 mg per ml and the second tank stores CBD with a volumetric density of 0.5 mg per mg, to maintain the THC to CBD ratio of 2:1, flow rates from each of the first tank and the second tank should be identical because of the difference in the volumetric densities of cannabinoids included in the different storage tanks.
  • Power supply 130 may include any type of power electronics known in the art.
  • power supply 130 may include a battery, a battery charging circuit, and a voltage regulator.
  • power supply 130 may be controlled by processor 115 to adjust vaporization temperatures at vaporizer 105. This may allow a user to adjust a rate of vaporization at vaporizer 105 or this may allow proper vaporization temperatures to be maintained overtime as a vaporizing element at vaporizer 105 ages.
  • vaporizer 105 may also include a temperature sensor that measures a vaporization or heater temperature.
  • a voltage applied to the vaporizing element may be adjusted to set or to maintain a desired vaporization temperature.
  • an optimal vaporization temperature is 380 degrees Fahrenheit (F) and a resistance of the vaporizing element at vaporizer 105 increases as that element is used
  • a voltage applied to the vaporizing element may be increased such that the 380 degree F vaporization temperature may be maintained at the vaporizing element.
  • an amount of current supplied to the vaporizing element may be monitored or adjusted to help maintain preferred vaporization temperatures.
  • cannabis network device 140 may communicate with the vaporizing device 105 to identify the contents stored in both a first and in a second container. This may allow processor 150 at the cannabis network device 140 to identify a recommended ratio of cannabinoids used to control the mixing of different extracts at vaporizer 105 such that a user can inhale vapors with the identified ratio of cannabinoids.
  • extract database 155 may store properties, such as biomass origin, cannabinoid concentrations, volumetric densities, extract production methods, etc.
  • Processor 150 may execute instructions out of memory 145 to collect user information that may be stored in user database 180.
  • user database may store information that identifies that a particular user suffers from chronic pain or that the user has sleep problems.
  • Instructions executed by processor 150 may include program code of a mixer control software module, the execution of these instructions may then allow processor 150 to combine data accessed at extract database 155, combination database 175, and user database 180 to identify attributes of extracts stored in the first and the second tank at vaporizer 105.
  • This attribute data may include a cannabinoid profile, volumetric densities, or other ingredients that are stored in the storage tanks at vaporizer 105.
  • Data may then be sent to vaporizer 105 from cannabis network device 140 via communication interface 160, communication network 135, and communication interface 125 by further instructions included in the mixer control software module at cannabis network device 140.
  • the data sent from cannabis network device 140 may then set the flow rates from both of the storage tanks at vaporizer 105, according to an optimal cannabinoid ratio that was identified after accessing the cannabinoid combination database 175 such that this optimal cannabinoid ratio may be delivered to the user of vaporizer 105.
  • User database 180 may store user information that identifies connected vaporizing apparatuses. This user information may include information about desired recreational or medical effects of particular users.
  • the cannabinoid combination database 175 may store optimal ratios of cannabinoids to be used for different desired effects, such as sleep, pain relief, etc.
  • the data stored in cannabinoid combination database 175 may be populated with data by verified studies and this data may be updated overtime.
  • processor 150 executing instructions out of memory 145 may access extract database 155 to identify cannabinoids and other data associated with content stored in the first an in the second storage tank at vaporizer 105.
  • Processor 150 may then access user database 180 to identify any ailments or preferences of a user and then processor 150 may access combination database 175 when preparing to send setting information to vaporizer 105 via communication interface 160.
  • FIG. 2 illustrates a vaporizer device that vaporizes controlled ratios of cannabinoids and provides vapors with the controlled ratios for inhalation.
  • the vaporizer assembly 210 of FIG. 2 includes a first tank 220, a second tank 230, a mixer 240, mouth piece 250, a user interface 260 (e.g. a display or user accessible control), a central processing unit
  • the CPU 270 may execute instructions out of memory when performing any of the functions consistent with operation of vaporizing cannabinoids as discussed in respect to the vaporizing device 105 of FIG. 1.
  • Mixer 240 may include various parts, examples of which are shown in FIGS 3-4 of this disclosure.
  • Mixer 240 may include pumps, valves, heaters, or other elements that are used to control the flow of materials from each of tank 1 and tank 2 of FIG. 2 to a vaporizing element.
  • mixer may preheat both tank 1 and tank 2 as pumps or valves included in mixer 240 allow a flow of materials to be provided to a vaporizing element included in (not illustrated in FIG. 2) vaporizer assembly 210 when power button 290 is depressed.
  • Mouthpiece 250 allows a user to suck in and inhale vapors produced by vaporizer assembly 210 as those vapors are produced.
  • Pumps or valves discussed in the present disclosure may be referred to as flow devices that may provide a flow of liquids or that may restrict the flow of liquids to a vaporizing element of a vaporizer.
  • FIG. 3 illustrates a portion of a vaporizer device that may be used to mix contents from different storage tanks in desired ratios as the mixed contents are provided to a vaporizing element.
  • FIG. 3 includes a first tank 310, a second tank 320, sensors 330, tubes/pipes 340, pump or valve 360, pump or valve 370, vaporizing element (VPRZ) 380, and mouthpiece 390.
  • mixer 350 in FIG. 3 includes tubes/pipes 340, pump or valve 360, and pump or valve 370 that may be used to mix regulated flows of materials from each of tanks 310 and 320 as those flows are provided to vaporizing element 380.
  • Sensors 330 may be sensors that senses the presence or absence of liquids included in each of tank 310 and 320. Data sensed by sensors 330 maybe used to identify whether a particular tank is empty. For example, sensors 330 may be coupled to control electronics, analog or digital, that provide information to users such that a user can replace or refill an empty tank. While not illustrated in FIG. 3, sensors included in a vaporizer consistent with the present disclosure may include level sensors or flow sensors that may allow control circuits in a vaporizer to monitor liquid levels in tanks 310 & 320 or flows of liquids through tubes 340 when a vaporizer is being used by a user.
  • pumps When pumps are used, these pumps may be a type of miniature electronic machine that are commonly referred to as MEMS. Types of pumps that may be used include a piezoelectric pump, a peristaltic pump, or a diaphragm pump, for example. These pumps may be controlled to pump a cannabinoid containing liquid from respective storage tanks at a vaporizer device by controlling the speed of the pump or by controlling a pump duty cycle.
  • valves When valves are used, these valves may also be a type of MEMS device. Valves may be controlled by a control system that controls how open or closed a valve is. For example a first valve coupled to tank 310 may be opened 50% and a valve coupled to tank 320 may be opened 25% when a vaporizer is used. Alternatively, valves maybe pulsed on and off as desired. In another example, a first valve coupled to tank 310 may be fully opened when a second valve coupled to tank 320 is fully opened and then fully closed with a 50% duty cycle. As such, valves included in a vaporizer may control the flow of cannabinoid containing materials in various ways. A user sucking on mouthpiece 390 may cause a flow of materials (e.g. like sucking on a straw) or may assist the flow of materials to vaporizing element 380. In certain instances, both pumps and valves may be used to control the flow of materials to vaporizing element 380.
  • a control system that controls how open or closed a valve is.
  • FIG 4 illustrates an alternative portion of a vaporizer device that may be used to mix contents from different storage tanks in desired ratios as the mixed contents are provided to a vaporizing element.
  • FIG.4 includes a first tank 410, a second tank 420, a first pump or valve 430, a second pump or valve 440, tubes 450, vaporizing element 460, and mouthpiece 470.
  • gravity may assist in moving materials from these tanks to tubes 450 when the vaporizer is in an upright orientation.
  • pumps and/or valves 430/440 may be used to provide flows of mixed materials to a vaporizer heating element.
  • MEMS pumps and/or valves may be controlled by a control circuit to provide desired flows of materials from each of tanks 410 and 420.
  • the control of these pumps or valves may allow virtually any combination of materials from tank 410, 420, or from both tanks 410 & 420 to flow to vaporizing element 460.
  • a flow of materials may be provided from only one tank or material flows may be provided from both tanks according to virtually any desired ratio.
  • 100% of a flow of materials may be provided 100% from tank 1 or 2.
  • a mixed flow provided to vaporizing element 460 may include 75% from tank 1 and 25% from tank 2.
  • virtually any combination may be set (e.g.
  • Each of these settings may correspond to a specific cannabinoid ratio and of course these flow rates may be adjusted to provide a normalized ratio in instances when each of the tanks contain a different measure of cannabinoids per unit volume (e.g. milligrams per milliliter) of materials contained within the different tanks.
  • FIG. 4 illustrates vaporizer element being located above tanks 410 and 420
  • this element may be located below tanks 410 and 420.
  • it may be placed next to pumps or valves 430 & 440.
  • valves may be preferred to control the flow of materials vaporizer element 460 as gravity and a person sucking on mouthpiece 470 may cause materials from tanks 410 and 420 to flow to vaporizer element 460.
  • FIG. 5 is a flowchart illustrating an exemplary method for preprogrammed multiple tank variable input vaporization via a cannabinoid network device. The steps of FIG. 5 may be performed by the cannabinoid network device 140 of FIG. 1.
  • FIG. 5 begins with a first step 505, where extract profiles are received from a vape (vaporizer) device.
  • extract profiles may have been received after a communication session with a vape device has been established.
  • the information received in step 505 may identify a reference number that can be used to identify profiles of extracts at a vape device.
  • These extract profiles may identify types of cannabinoids included in particular tanks at a vape device.
  • An extract profile may identify that materials included in tank 1 of a vape device include both THC and CBD in a 1:1 ratio.
  • an extract provide may include a volumetric density of specific cannabinoids included in a tank.
  • the data received in step 505 may have been received after a query was sent to a vaporizing apparatus.
  • extract-solution one stored in a first tank may have a THC:CBD ratio of 15:1 (with 15% of THC and 1% of CBD) and extract-solution two stored in a second tank may have a THG:CBD ratio of 1:2 (with 5% THC and 10% CBD).
  • a query may be conducted on a user database to identify a user's desired effect in step 510.
  • the desired effect may be a recreational effect or a medically therapeutic effect.
  • a query may be conducted on the cannabinoid combination database to identify an optimal cannabinoid ratio for a given desired effect in step 515.
  • An example of a desired recreational effect may call for a 10:1 THC:CBD ratio, or an example of a medical therapeutic effect may be a THG:CBD ratio of 1:1 for sleep assistance in a chronic pain patient.
  • the percentages associated with particular extract-solutions may correspond to a density of cannabinoids distributed in a liquid that contain other materials.
  • an extract containing solution with the THG:CBD ratio of 15:1 that contains 15% THC and 1% CBD may contain propylene glycol and cannabis plant terpenes that comprise 84% of the extract-solution one.
  • extract solution two with the THC to CBD ratio of 1:2 contains 1% THC and 2% CBD may also include propylene glycol and/or other materials.
  • a selected cannabinoid ratio of 10:1 has been selected for administration, relative volumes of the extract-solution one and extract-solution two to combine to reach this ratio could be identified by volumetric equations or by accessing data stored in lookup tables.
  • these percentages correspond to a number of milligrams or to a number of percentages of cannabinoids per milliliter (ml) of an extract- solution.
  • a combination of 1 ml of extract-solution one and 1 ml of extract solution two would create a combined extract-solution with a 16:3 ratio. Since this ratio far exceeds the selected ratio, a number of ml of each extract solution could be identified using a series of equations or this number of ml of each extract-solution to achieve a desired ratio could be looked up in a stored table of values.
  • the ratio of extract-solution one to extract-solution two may be calculated to provide the requested cannabinoid ratio retrieved from the cannabinoid combination database in step 520.
  • the ratio of extract-solution one (THG:CBD 15:1) to extract-solution two (THG:CBD 5:10) may be 2.8 parts of extract two for each part of extract-solution one.
  • these relative parts could be associated with a number of milliliters of extract-solutions provided from different tanks at a vaporizer.
  • the desired ratio of THG:CBD is 10:1, and step 520 of FIG. 5 may identify that 0.28 parts of extract-solution two for each part of extract- solution one should be vaporized to achieve the desired result.
  • the calculated ratio parameters of extract one to extract two may then be sent to a vape device in step 525.
  • a query for this information maybe received from a vape device and that information may also be provided to the vape device in step 525 of FIG. 5.
  • the vape device may then be polled for any user-made adjustments to the current ratio in step 530.
  • the polling of the vape device may result in data being received that identifies that the user has manually changed vaping parameters from parameters sent to the vape device in step 525.
  • Such a query may be used to identify whether it appears that a different user is actually using the vape device.
  • a high THC concentration may indicate that another person may be using the vape device.
  • such a determination may result in a message being sent to the vape device that disables the device.
  • a query may be conducted on the user database for a defined limit in the user's profile.
  • a defined limit may be a medical patient who has demonstrated in the past an adverse reaction to THG:CBD levels exceeding 2:1.
  • Determination step 535 may identify that a new ratio exceeds limits set by data stored at a user database. When determination step 535 identifies that the ratio exceeds the limits stored at the user database, program flow may move to step 545, where changes to the ratio may be disallowed. This process may include sending data to the vape device that does not allow the new ratio to be used by the vape device. When determination step 535 identifies that the new ratio does not exceed limits imposed by the data stored at the user database, a query may be conducted on the cannabinoid combination database for prescribed or recommended limits regarding the ratio in determination step 540. An example of prescribed limits may be a diminishing effect of THC when the THC:CBD ratio exceeds 10:1.
  • a mix of cannabinoids may be adjusted in a direction requested by a user of the vape device, this adjustment may result in altering a ratio to a point that does not exceed a limit identified in the cannabis combination database.
  • determination step 540 identifies that a limit in the cannabis combination database has been exceeded, program flow may move to step 545 where an adjustment to the ratio is not allowed.
  • determination step 540 identifies that a user adjustment is within the limits of the cannabis combination database
  • program flow may move to step 550 where the adjustment to the mixer ratio may be allowed.
  • program flow moves to determination set 555 that identifies whether the vape is still in use, when yes program flow moves back to step 530 the vape device may once again be polled for user adjustments.
  • program flow may end in step 560 of FIG.5.
  • Table 1 includes data that may be stored at a user database.
  • user database contains the therapeutic and recreational cannabinoid ratios for each user of the system.
  • Table 1 includes a series of columns that identify a user, a product name, a therapeutic ratio, types of therapeutic cannabinoids that a user uses, recreational cannabinoids that a user used, a ratio limit, and a selected use ratio.
  • a first row in table 1 identifies that user 1 prefers a therapeutic ratio of 1 :1 of THC to CBD.
  • that 1:1 ratio may be selected.
  • a THG:CBD ratio of 10:1 may be selected for recreational purposes.
  • the ratio limit of 12:1 THC to CBD in table 1 may be used by a cannabis network device to prevent a user from vaporizing materials that include greater than a 12 to 1 ratio of THC to CBD.
  • user ratio limits may also be persistently stored at a vape device and a processor at the vape device may compare settings at the vape device with these user limits. In instances when the processor at the vape device identifies that these limits have been exceeded, ihe processor may reset the settings to levels that do not exceed the user limits.
  • each of the rows in table 1 cross reference different users (users 1-3) with various product names (Up and Down - and Evening Zippo), cannabinoids THC:CBD, cannabinoid ratios (therapeutic and recreational), ratio limits (12:1 & 5:1 THC to CBD), and selected cannabinoid ratios (10:1, 9:1, & 4:1).
  • FIG. 6 illustrates an alternative network environment in which a system for preprogrammed multiple tank variable input vaporization may be implemented.
  • FIG. 6 includes vaporizer device 610, a user device 620, a cannabis network device 640, where user device 620 communicates with cannabis device network via communication network 630 and where user device communicates with vaporizer device 610.
  • the communications performed between user device 620 and cannabis network device 640 may be performed using one type of communication technology and communications between user device 620 and vaporizer device 610 may be performed using a second type of communication technology.
  • the first type of communication technology may include cellular communications, 802.11 communications, and/or communications sent via a wired network.
  • the second type of communications may include Bluetooth communications, near field data communications (NFC), 802.11 communications, or proprietary short distance communications.
  • User device 620 may be any user device known in the art such as a cell phone, a computer, or a tablet computer.
  • User device 620 may include a memory, a processor that executes instructions out of the memory, and communication interfaces. Operations performed by the processor at user device 620 may be performed after the user device downloads a program application (APP) from an online server (e.g. from a server at the Apple APP store).
  • APP program application
  • the design of vaporizer devices consistent with the present disclosure could be simplified as compared to designs were the vaporizer device directly communicates with the cannabis network device 640. For example, such a vaporizer device might be only require a single Bluetooth communication interface that would enable that device to send and receive information in communications with user device 610, and user device 620 could then communicate with cannabis device network 640.
  • vaporizer apparatus that includes a set of control electronics that receive communications from other computing devices
  • other embodiments of apparatus consistent with the present disclosure may not include electronics that receive communications from other computing devices.
  • These other embodiments may include a two or more storage tanks, where each tank is coupled to a pump or valve that can be manually adjusted.
  • the actions of a pump or pumps may be controlled with a set of rheostats that changes a voltage or current provided to a respective pump.
  • a set of manual valves may allow a user to adjust flow rates from a set of respective storage tanks.
  • FIG. 7 illustrates a computing system that may be used to implement an embodiment of the present invention.
  • the computing system 700 of FIG. 7 includes one or more processors 710 and main memory 720.
  • Main memory 720 stores, in part, instructions and data for execution by processor 710.
  • Main memory 720 can store the executable code when in operation.
  • the system 700 of FIG. 7 further includes a mass storage device 730, portable storage medium drive(s) 740, output devices 750, user input devices 760, a graphics display 770, peripheral devices 780, and network interface 795.
  • processor unit 710 and main memory 720 may be connected via a local microprocessor bus, and the mass storage device 730, peripheral device(s) 780, portable storage device 740, and display system 770 may be connected via one or more input/output (I/O) buses.
  • I/O input/output
  • Mass storage device 730 which may be implemented with a magnetic disk drive or an optical disk drive, is a non-volatile storage device for storing data and instructions for use by processor unit 710. Mass storage device 730 can store the system software for implementing embodiments of the present invention for purposes of loading that software into main memory 720.
  • Portable storage device 740 operates in conjunction with a portable nonvolatile storage medium, such as a FLASH memory, compact disk or Digital video disc, to input and output data and code to and from the computer system 700 of FIG. 7.
  • a portable nonvolatile storage medium such as a FLASH memory, compact disk or Digital video disc
  • the system software for implementing embodiments of the present invention maybe stored on such a portable medium and input to the computer system 700 via the portable storage device 740.
  • Input devices 760 provide a portion of a user interface.
  • Input devices 760 may include an alpha-numeric keypad, such as a keyboard, for inputting alpha-numeric and other information, or a pointing device, such as a mouse, a trackball, stylus, or cursor direction keys.
  • the system 700 as shown in FIG. 7 includes output devices 750. Examples of suitable output devices include speakers, printers, network interfaces, and monitors.
  • Display system 770 may include a liquid crystal display (LCD), a plasma display, an organic light-emitting diode (OLED) display, an electronic ink display, a projector-based display, a holographic display, or another suitable display device.
  • Display system 770 receives textual and graphical information, and processes the information for output to the display device.
  • the display system 770 may include multiple-touch touchscreen input capabilities, such as capacitive touch detection. resistive touch detection, surface acoustic wave touch detection, or infrared touch detection. Such touchscreen input capabilities may or may not allow for variable pressure or force detection.
  • Peripherals 780 may include any type of computer support device to add additional functionality to the computer system.
  • peripheral device(s) 780 may include a modem or a router.
  • Network interface 795 may include any form of computer interface of a computer, whether that be a wired network or a wireless interface. As such, network interface 795 may be an Ethernet network interface, a BlueTooth TM wireless interface, an 802.11 interface, or a cellular phone interface.
  • the components contained in the computer system 700 of FIG. 7 are those typically found in computer systems that may be suitable for use with embodiments of the present invention and are intended to represent a broad category of such computer components that are well known in the art.
  • the computer system 700 of FIG. 7 can be a personal computer, a hand held computing device, a telephone ("smart" or otherwise), a mobile computing device, a workstation, a server (on a server rack or otherwise), a minicomputer, a mainframe computer, a tablet computing device, a wearable device (such as a watch, a ring, a pair of glasses, or another type of
  • the computer can also include different bus configurations, networked platforms, multi-processor platforms, etc.
  • the computer system 700 may in some cases be a virtual computer system executed by another computer system.
  • Various operating systems can be used including Unix, Linux, Windows, Macintosh OS, Palm OS, Android, iOS, and other suitable operating systems.
  • Nan-transitory computer-readable storage media refer to any medium or media that participate in providing instructions to a central processing unit (CPU) for execution. Such media can take many forms, including, but not limited to, non-volatile and volatile media such as optical or magnetic disks and dynamic memory, respectively. Common forms of non-transitory computer-readable media include, for example, a floppy disk, a flexible disk, a hard disk, magnetic tape, any other magnetic medium, a CD-ROM disk, digital video disk (DVD), any other optical medium, RAM, PROM, EPROM, a FLASH EPROM, and any other memory chip or cartridge.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Automation & Control Theory (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Signal Processing (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un système de vaporisation d'au moins deux extraits, dont au moins un contient au moins un cannabinoïde en un rapport souhaitable sur le plan thérapeutique ou récréatif. Le système comprend un appareil de vaporisation avec au moins deux contenants distincts pour un matériau vaporisable. Les concentrations de cannabinoïdes comprises dans les réservoirs de stockage peuvent être identifiées et ces concentrations de cannabinoïdes peuvent être comparées à des informations qui identifient des préférences d'utilisateur qui correspondent à un mélange de matériaux provenant des réservoirs de stockage respectifs. Le vaporisateur peut être conçu pour fournir des flux de matériaux à un élément chauffant qui vaporise des cannabinoïdes inclus dans le mélange de matériaux lorsqu'une personne inhale des vapeurs créées au niveau du dispositif de vaporisateur selon un rapport souhaité. Un dispositif informatique peut surveiller les informations reçues d'un dispositif de vaporisation lorsqu'il s'assure qu'un rapport de cannabinoïde sélectionné ne dépasse pas une limite rencontrée dans une base de données.
PCT/IB2020/051101 2019-02-12 2020-02-12 Vaporisateur à entrée variable à réservoir multiple préprogrammé Ceased WO2020165777A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962804388P 2019-02-12 2019-02-12
US62/804,388 2019-02-12

Publications (1)

Publication Number Publication Date
WO2020165777A1 true WO2020165777A1 (fr) 2020-08-20

Family

ID=72044059

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2020/051101 Ceased WO2020165777A1 (fr) 2019-02-12 2020-02-12 Vaporisateur à entrée variable à réservoir multiple préprogrammé

Country Status (1)

Country Link
WO (1) WO2020165777A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220339372A1 (en) * 2021-04-27 2022-10-27 Perry S. Kaye Substance Delivery Device and Methods
WO2023002192A1 (fr) * 2021-07-22 2023-01-26 Nicoventures Trading Limited Système de génération et de distribution d'aérosol pour actifs carboxylés
US11701479B1 (en) * 2022-02-01 2023-07-18 Green Sky Creations LLC Systems, devices, and methods for administering cannabinoid mixtures
USD1036766S1 (en) 2022-11-07 2024-07-23 Vape Mixer Corp. Vaporizer
WO2025037101A1 (fr) * 2023-08-11 2025-02-20 Olfactive London Limited Dispositif et procédé de distribution de médicament
US12402660B2 (en) 2022-03-22 2025-09-02 Curb Living, Inc. Handheld vaping implement

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150047662A1 (en) * 2012-04-12 2015-02-19 Jt International Sa Aerosol-generation devices
US20160089508A1 (en) * 2014-09-25 2016-03-31 ALTR, Inc. Vapor inhalation device
US20160325055A1 (en) * 2015-05-08 2016-11-10 Lunatech, Llc Device To Deliver Cannabidiol And Associated Compounds To Promote Health
WO2017185051A1 (fr) * 2016-04-22 2017-10-26 Pax Labs, Inc. Dispositifs aérosol ayant des matériaux compartimentés
US20180153208A1 (en) * 2015-07-13 2018-06-07 Philip Morris Products S.A. Producing an aerosol-forming composition
WO2018146453A1 (fr) * 2017-02-10 2018-08-16 British American Tobacco (Investments) Limited Système de fourniture de vapeur
US20180263296A1 (en) * 2012-06-28 2018-09-20 Rai Strategic Holdings, Inc. Reservoir and heater system for controllable delivery of multiple aerosolizable materials in an electronic smoking article

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150047662A1 (en) * 2012-04-12 2015-02-19 Jt International Sa Aerosol-generation devices
US20180263296A1 (en) * 2012-06-28 2018-09-20 Rai Strategic Holdings, Inc. Reservoir and heater system for controllable delivery of multiple aerosolizable materials in an electronic smoking article
US20160089508A1 (en) * 2014-09-25 2016-03-31 ALTR, Inc. Vapor inhalation device
US20160325055A1 (en) * 2015-05-08 2016-11-10 Lunatech, Llc Device To Deliver Cannabidiol And Associated Compounds To Promote Health
US20180153208A1 (en) * 2015-07-13 2018-06-07 Philip Morris Products S.A. Producing an aerosol-forming composition
WO2017185051A1 (fr) * 2016-04-22 2017-10-26 Pax Labs, Inc. Dispositifs aérosol ayant des matériaux compartimentés
WO2018146453A1 (fr) * 2017-02-10 2018-08-16 British American Tobacco (Investments) Limited Système de fourniture de vapeur

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220339372A1 (en) * 2021-04-27 2022-10-27 Perry S. Kaye Substance Delivery Device and Methods
WO2023002192A1 (fr) * 2021-07-22 2023-01-26 Nicoventures Trading Limited Système de génération et de distribution d'aérosol pour actifs carboxylés
JP2024528838A (ja) * 2021-07-22 2024-08-01 ニコベンチャーズ トレーディング リミテッド エアロゾル生成、及びカルボキシル化活性物のための送達システム
JP7742479B2 (ja) 2021-07-22 2025-09-19 ニコベンチャーズ トレーディング リミテッド エアロゾル生成、及びカルボキシル化活性物のための送達システム
US11701479B1 (en) * 2022-02-01 2023-07-18 Green Sky Creations LLC Systems, devices, and methods for administering cannabinoid mixtures
US20240226463A9 (en) * 2022-02-01 2024-07-11 Green Sky Creations LLC Systems, devices, and methods for administering cannabinoid mixtures
US12402660B2 (en) 2022-03-22 2025-09-02 Curb Living, Inc. Handheld vaping implement
USD1036766S1 (en) 2022-11-07 2024-07-23 Vape Mixer Corp. Vaporizer
WO2025037101A1 (fr) * 2023-08-11 2025-02-20 Olfactive London Limited Dispositif et procédé de distribution de médicament

Similar Documents

Publication Publication Date Title
WO2020165777A1 (fr) Vaporisateur à entrée variable à réservoir multiple préprogrammé
US12364807B2 (en) System and method for maximum insulin pump bolus override
US10918785B2 (en) Integration of infusion pump with remote electronic device
US11701479B1 (en) Systems, devices, and methods for administering cannabinoid mixtures
US20200372993A1 (en) Systems, methods, and apparatus for tailored dosing of cannabis formulations
JP2008541280A (ja) 薬品投与データ設定アナライザ
US20220071294A1 (en) Smart vaporizer
US20180369478A1 (en) Medical infusion pumps and systems
Wilson et al. Intraocular MDMX Inhibition by ALRN-6924: A Targeted Strategy to Reactivate p53 in Retinoblastoma
Horvath et al. Drug release kinetics of the Port Delivery System with ranibizumab (PDS): platform technology for continuous retinal drug delivery
Lim et al. Off-pump coronary artery bypass grafting may prevent acute renal failure in patients with non-dialysis dependent chronic renal dysfunction: an aggregate meta-analysis
Culp et al. Risk of corneal graft rejection in COVID-19 vaccinated patients in the 120-day postoperative period: a multi-healthcare system analysis
Fauth Excel Worksheet for Calculating an Adapted Nutrition Plan
Koo et al. Cataract surgery related complications in patients with a history of intravtireal injections
US20210082560A1 (en) Automatic safety adjustment system
Belkin et al. Outcomes Following Mitraclip in Advanced Heart Failure Patients: A Meta-Analysis
Thorne et al. Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study
Kyriakopoulos et al. (768) Hospital Readmissions in Patients Supported with Durable Centrifugal-Flow Left Ventricular Assist Devices
US20210057073A1 (en) Mixer and dispenser for liquid medicine
Ayoub et al. Association between intravitreal TriMoxi and IOP outcomes in microincisional glaucoma/cataract surgery
Ghafourian et al. Plasma Donor-Derived Cell-Free DNA Levels are Not Affected by Prednisone Dose nor Time after Heart Transplant: Pilot Data from DOAR and SHORE
Tobias et al. Performance of the On-Q pain infusion device during hyperbaric therapy
Kis et al. Comparison of Aerosol Delivery of a Standard Nebulizer With a T-Piece vs Nebulizing Using a Y-Piece Simultaneous With High-Flow Oxygen Therapy
CN119524254A (zh) 一种麻醉机、输注设备、麻醉系统及其控制方法
Lo et al. Refillable MEMS Drug Delivery Pump for Chronic Ocular Diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20755862

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20755862

Country of ref document: EP

Kind code of ref document: A1